Skip to main content
PLOS One logoLink to PLOS One
. 2020 May 29;15(5):e0233730. doi: 10.1371/journal.pone.0233730

The yield of community-based tuberculosis and HIV among key populations in hotspot settings of Ethiopia: A cross-sectional implementation study

Z G Dememew 1,*, D Jerene 1, D G Datiko 1, N Hiruy 1, A Tadesse 2, T Moile 3, D Bekele 4, G Yismawu 5, K Melkieneh 1, B Reshu 1, P G Suarez 6
Editor: Hasnain Seyed Ehtesham7
PMCID: PMC7259557  PMID: 32469997

Abstract

Objective

To determine the yield of tuberculosis (TB) and the prevalence of Human Immuno-deficiency virus (HIV) among key populations in the selected hotspot towns of Ethiopia.

Methods

We undertook a cross-sectional implementation research during August 2017-January 2018. Trained TB focal persons and health extension workers (HEWs) identified female sex workers (FSWs), health care workers (HCWs), prison inmates, homeless, internally displaced people (IDPs), internal migratory workers (IMWs) and residents in missionary charities as key and vulnerable popuaiton. They carried out health education on the importance of TB screening and HIV testing prior to recruitment of the study participants. Symptomatic TB screening and HIV testing was done. The yield of TB was computed per 100,000 background key population.

Results

A total of 1878 vulnerable people were screened, out of which 726 (38.7%) presumptive TB cases and 87 (4.6%) TB cases were identified. The yield of TB was 1519 (95% CI: 1218.1–1869.9). The highest proportion (19.5%) and yield of TB case (6,286 (95% CI: 3980.8–9362.3)) was among HCWs. The prevalence of HIV infection was 6%, 67 out of 1,111 tested. IMWs and FSWs represented 49.3% (33) and 28.4% (13) of the HIV infections, respectively. There was a statistically significant association of active TB cases with previous history of TB (Adjusted Odds Ratio (AOR): 11 95% CI, 4.06–29.81), HIV infection (AOR: 7.7 95% CI, 2.24–26.40), and being a HCW (AOR: 2.42 95% CI, 1.09–5.34).

Conclusions

The prevalence of TB in key populations was nine times higher than 164/100,000 national estimated prevalence rate. The prevalence of HIV was five times higher than 1.15% of the national survey. The highest yield of TB was among the HCWs and the high HIV burden was detected among the FSWs and IMWs. These suggest a community and health facility based integrated and enhanced case finding approaches for TB and HIV in hotspot settings.

Introduction

The incidence of TB has dropped in most regions of the world, including in Ethiopia [1]. However, the disease is largely concentrated in vulnerable or socially excluded populations and high-risk settings [2]. If vulnerable populations are not put at the forefront of any intervention, they will continue to be among the missed TB cases [1,2].

Ethiopia was estimated to miss 58,893 (34%) of expected TB cases in 2018 [3]. According to 2010 unpublished Ethiopian TB report, about 59% of the missed TB cases could be due to failure to detect TB in the community and among vulnerable populations. In order to identify the missed TB cases, the country has adopted the global target to identify at least 90% of TB cases among key populations by 2025 [4]. Hence, the national TB program prepared an operational guide and implementation plan on key affected populations for TB in 2017 [5].

Key and vulnerable populations for TB are defined and identified based on increased risk of TB disease due to biological and socioeconomic factors, lack of access to health services for diagnosis and treatment, and the experience of human rights violations [5]. Country-specific situations can be useful in defining key and vulnerable groups for TB [6]. Accordingly, Ethiopia has identified people living with HIV, people with diabetes, children, elders, prisoners, university residents, contacts of TB patients, miners or internal migratory workers (IMWs), cross-border refugees, internally displaced people (IDPs), homeless, female sex workers (FSWs), HCWs as key and vulnerable populations for TB [5].

On the other hand, there has been slowing or stabilizing general HIV epidemic over the last decade in Ethiopia[7]. The prevalence of HIV was 1.5% in 2011 [8] and decreased to 1.15% in 2018 [9]. The estimated number of deaths declined from 11,000 in 2015 to 5,000 in 2018 [9]. Also, the rate of TB/HIV co-infection significantly decreased from 18% in 2012 to 7% in 2017 [8,9]. Nevertheless, the burden of HIV in Ethiopia remained to be congregated in the hotspot settings such as urban areas and big cities [7,10]. Besides, the HIV epidemic is slowly rising among the high-risk population groups such as FSW and their partners [11]. Hence, it is paramount to assess HIV among the key populations in the hotspot settings of Ethiopia to deal with HIV and HIV related TB. This could contribute to the achievement of the three 90’s of the global targets for both TB [4] and HIV [12].

Less evidence exists, however, about the prevalence of TB and HIV among the key and vulnerable population groups in Ethiopia. Moreover, it is essential to identify vulnerable populations based on their context [6] i.e in the hotspot setting for HIV and TB. Therefore, this study tried to determine the yield of enhanced TB case finding and the prevalence of HIV among the vulnerable population at the selected hotspot settings of Ethiopia.

Materials and methods

Settings

Ethiopia is the second-most populous nation in Africa, with a population of about 110 million [13]. It ranks 10th among the 30 high-TB-burden countries, with TB incidence of 164/100,000 in 2018 [3]. Harar, Dire Dawa, Woldiya, Shakiso, and Adola were the five towns in Ethiopia with a TB/HIV co-infection rate higher than 10% [1416] (S1 Fig). These towns contribute to 2.7% of the national population. Geographic clustering of high-risk sub populations exists in these towns due to gold mining, factories, poverty, and cash crops, paving the way for high TB and HIV transmission—hence the term hotspot setting.

Study design and interventions

We undertook a cross-sectional implementation research during August 2017-January 2018 with funding from the US Agency for International Development under the Challenge TB project. In Ethiopia, Challenge TB provided support to the national TB program in nine of the 11 administrative regions. We initiated the study after consultation with regional, zonal, and district TB focal persons. The project built the capacity of the program managers, HCWs, and HEWs on TB and TB/HIV screening, diagnosis and treatment. The project also technically and financially assisted supportive supervisions and program reviews on TB and TB/HIV. Improving sputum specimen and patient referral system, and strengthening data quality and reporting system through the district health information system (DHIS) were another support issued to the national TB program by Challenge TB project.

Identification of hotspot settings and key populations

We selected the five study towns as the hotspot for TB and HIV because of their higher TB/HIV co-infection rate [1416] as compared to other towns in the country. All the missionary residents, hotels, mining or construction offices, correctional facilities, health facilities, street tukuls of the homeless and refugee centers in the five towns were selected as sites of the data collection.

TB focal persons, HCWs that coordinate comprehensive TB and TB/HIV activities, and HEWs—the female community workers employed to execute the health extension program—were trained on the procedures of defining [5,6 &13], identifying and sampling the key populations in the data collection areas. They were also trained on the information they need to deliver during health education to the key population before recruitment; such as TB transmission, purpose of the study and the advantages of being screened for TB and HIV. Hence, they carried out 15–20 minutes of health education before recruitment and data collection among the key population to enhance the TB screening and HIV testing.

They recruited FSWs at the hotels after obtaining permission from the owner of the hotel. The HEWs and TB focal persons deployed homeless individuals in the street. IDP, HCWs, prison inmates and IMW were recruited after the heads of the offices of road construction and mining (for IMW), health care facility (for HCWs), correctional facility (prisoners) and refugee centers (IDPs) were approached. The HCWs were clinicians, such as registered nurses, interns, medical doctors and public health officers that were involved in managing patients in public health facilities found in the study towns. IDPs were those individuals that were displaced from Somalia region of the country to Harari region due to ethnic conflict during the study period. The IDPs arrived at refugee center near Harar town 4–6 weeks prior to data collection.

The key population that understood the objective of the study and willing to participate after the health education, and in a relative good health status were involved in the study. Those who understood the aim of the study but refused to be part of the study and/or were sick during the data collection were excluded (Fig 1).

Fig 1. The flow chart shows sampling and selection of the key population.

Fig 1

Predefined key population are those whose number had already been documented and reported by the study towns’ health offices. The “defined during data collection” key population were those whose number were not known by the study towns’ health office and their background population was determined during the data collection period. The sampling frame was taken as the total key population in the study towns, and thus the background population to compute the yield or prevalence of TB. Bold arrow is to show the crude procedure one after the other; listing the sampling frame, random selection of one-third of the sampling frame, approaching for TB screening. Light arrow is to show the same procedure in each key population; FSW (female sex workers), IMW (internal migratory workers), IDP (internally displaced people), HCW (health care workers), missionary residents are the one supported by the charity organization. Most of the refusals were from HCW and FSW for they were busy, and from prison inmates. The malaria illness and other acute febrile illness made the other key population difficult to participate in the study.

Sampling the key population

There were a total of 3,400 prison inmates, 250 residents of facilities operated by charities and 350 HCWs reported from the five towns’ health office. These numbers were taken as a sampling frame. One-third of the sampling frame from each of these key population was randomly selected to be a study population in the five towns. Excel sheet was used to undertake the simple random selection of the study population from the sampling frame for the prison inmates, missionary residents and HCWs.

However, the number for FSWs, IMWs, IDPs and homeless could not be obtained. Hence, the sampling frame was established during the data collection. That is, when the HEWs and TB focal persons visited the FSWs in the hotels, IMWs at the workplace, IDPs in the refugee centers and homeless in the street, they registered these key populaiton on excel sheet (sampling frame). Then one-third of the sampling frame was randomly selected to be the study participants. Accordingly, there were 639 FSWs, 730 IMWs, 315 IDPs, and 55 homeless individuals that were registered as sampling frame from where random sampling was carried out during the study period.

All in all, 5729 key populations were taken as sampling frame or background key population in the five study towns. A total of 1929 vulnerable population were selected randomly and approached for TB screening; 1125 prison inmates, 87 residents of facilities operated by charities, 123 HCWs, 225 FSWs, 245 IMWs, 105 IDPs and 19 homeless individuals. About 1878 (97%) of them accepted the screened for TB; 221 FSWs, 237 IMWs, 1112 prison inmates, 79 residents of facilities operated by charities, 113 HCWs, 102 IDPs, and 14 homeless (Fig 1).

Screening and diagnosis of TB, and HIV testing among the key population

The HEWs and TB focal persons carried out symptom-based screening for TB. At the same time, they did confidential HIV testing and counseling. An individual having cough, fever, and night sweating of more than two weeks or weight loss were taken as a presumptive TB case or positive screening test [17]. Nationally approved rapid HIV test kits were used for HIV testing. The identified presumed TB cases and HIV positive key populations were referred to the health facilities in study towns having TB DOTS and chronic HIV care services. These were the facilities with external quality control for diagnostic tests. At the health facilities, depending on their complaint, the presumed TB cases underwent clinical evaluation (history and physical examination), acid-fast bacilli (AFB) test, Gene X-pert test, fine needle aspiration (FNA) or chest X-ray. For a single key population, the time spent for recruitment, TB screening, HIV testing and counseling, and recording all the outcomes of TB screening and evaluation ranged from 15–20 minutes.

TB cases were categorized as bacteriologically confirmed pulmonary TB (PTB) cases where the diagnosis is made using AFB or Gene X-pert, clinically diagnosed smear-negative PTB if the diagnosed is based on clinical findings, and clinically diagnosed extra-PTB (EPTB) if the diagnosis is based on clinical evidence and the disease is out of the lung. The classification of TB was also made as drug-susceptible TB if the disease is responding to first-line anti-TB drug and Multi-drug resistance or rifampicin resistance TB (MDR-TB/RR-TB) if the TB disease is resistance at least to rifampicin and isoniazid [17]. The key populations that had already known their HIV status were also recorded.

Data source

The study coordinators prepared a register of key and vulnerable populations which the TB focal persons and HEWs used to record the number of people approached for TB screening, their sociodemographic characteristics, presumed TB cases, TB cases, and HIV status. The register of key and vulnerable population captured the information obtained from the individual key population and the outcomes of the clinical evaluation and laboratory investigations.

Data quality

We deployed two trained data entry clerks. The first carried out primary data entry and the second checked for discrepancies in the data. The study coordinators also supervised data collection and data entry for consistency and completeness.

Data analysis

The Epi Info statistical package (Version 7.2.2.16; Atlanta, Georgia: Centers for Disease Control and Prevention; 2018) was used for data entry and cleaning. We imported the data to Stata (College Station, Texas: StataCorp; 2013) for data analysis. Frequency, percentage, mean, and other descriptive statistics were used. The notified TB cases per 100,000 background key population and proportions were used to compute the prevalence of TB in the key population. Adjusting for sociodemographic characteristics in the key population, bivariate and multivariable (forward conditional) logistic regression—applying the odds ratio and 95% confidence interval (95% CI)—were used to determine factors associated with active TB in the key population. The independent variable was the presence of TB case. The dependent variables were sex (male and female), age (categorized based on the median, below and above 28 years), educational status (below high school, high school and above), marriage (married/with partner and non-married or without partner), HIV status (HIV positive and HIV negative), previous history of TB (having at least one episode of TB before and never had TB case), and type of key population (FSW, IWM, IDPs, HCWs).

Ethical considerations

The ethical review committee (ERC) of the respective regions of the study towns approved the study protocol. These were ERC of Oromia regional health bureau, Institutional Review Board (IRB) of the Amhara public health institute, the ERC of the research wing of Dire Dawa health bureau and ERC of Harari regional health bureau. We obtained support letters from the ERC and IRB of these regions and towns to communicate with the relevant local organizations and town health offices where the key population were found. We also sought and received informed written consent from the study participants before data collection. Permission was requested from the guardian and parents in case of children. Even though a separate consent requested for TB screening and HIV screening, it was asked one after the other; first for TB screening and then for HIV testing. All the key and vulnerable population were informed that it is their full right to exit from the study if they are not willing. However, all were getting a TB screening, evaluation and treatment services irrespective of their willingness or refusal to participate in the study. That is, the respective TB case and HIV positive key population were linked to and managed at the TB DOTS and chronic HIV care of the health facilities in the study towns.

Results

Sociodemographic characteristics

Of the 1,878 participants approached and screened for TB, 1326 (70.6%) were men. The mean and the median age were 30.5 years and 28 years (Range: 5–80 years), respectively. About half of the study participants were married and had attended at least primary school (Table 1). The detail of sociodemographic characteristic of each key population is described in S1 Table.

Table 1. Sociodemographic characteristics of the vulnerable population in the selected five towns of Ethiopia, August 2017- January 2018.

Variables Frequency Percent
Types of vulnerable populations
FSWs 221 11.77
IMWs 237 12.62
Prisoners 1,112 59.21
Residents of missionary charity facilities 79 4.21
Homeless people 14 0.75
IDPs 102 5.43
HCWs 113 6.02
Total 1,878 100
Sex
Female 552 29.39
Male 1,326 70.61
Total 1,878 100
Age in years
< 15 19 1.0
15–24 594 31.9
25–34 721 38.7
35–44 334 17.9
> 44 195 10.5
Total with age determined 1,863 100
Marital status
Married 911 50.36
Divorced/separated 245 13.54
Single/never married 636 35.16
Widowed 17 0.94
Total with marital status determined 1,809 100
Educational status
Primary school (1st-6th grade) 855 47.77
7th-8th grade 628 35.08
9th-12th grade 184 10.28
12th grade or above 123 6.87
Total with educational status determined 1,790 100

Screening and evaluation

One hundred and one (5.4%) of the screened vulnerable population had a history of previous TB treatment, and five of them (0.3%) were on treatment during data collection. Of the 1,878 screened, 726 (38.7%) were presumptive TB cases, of whom 210 (28.9%) were clinically evaluated, 126 (17.4%) were investigated using acid-fast bacilli (AFB) testing and 612 (84.3%) were tested by GeneX-pert. A total of 959 key population underwent at least a clinical evaluation or TB laboratory test. A total of 87 (4.6%) TB cases were identified and 65 (74.7%) were bacteriologically confirmed; 62 (95.4%) were drug susceptible TB and 3 (4.6%) were MDR-TB cases (Table 2). Note that five of the vulnerable (IMW) were already on treatment and had clinical EPTB (1) and PTB (4).

Table 2. Tuberculosis screening, evaluation, and final status of the vulnerable population in the five towns of Ethiopia, August 2017–January 2018.

Variables Frequency Percent
Previous TB episode
Had TB once 92 4.9
Had TB twice 9 0.5
On treatment now 5 0.3
Never 1,772 94.4
Total 1,878 100.0
Outcome of TB screening
Positive 726 38.7
Negative 1,152* 61.3
Total 1,878 100.0
Means of TB investigation
AFB 126 13.1
GeneXpert 612 63.8
Clinical only 210 21.9
Chest x-ray 9 0.9
FNA 2 0.2
Total evaluation done using at least one of the above criteria 959 100.0
Outcome of the investigation
No TB 1,748 93.3
TB diagnosed during the study period 87 4.6
Result could not be found 38 2.1
Total 1,873 100.0
Type and site of TB
Drug-susceptible TB
Bacteriologically confirmed PTB 62 71.3
Clinical extrapulmonary TB (EPTB) 11 10.3
Clinical pulmonary TB (PTB) 16 14.9
MDR-TB (all new and bacteriologically confirned PTB) 3 3.4
Total 92 100.0

The prevalence of TB, HIV, and TB/HIV co-infection among the vulnerable population

Of the 87 TB cases, 27 (31%) were prisoner inmates and 22 (25.3%) were HCWs. The highest proportion of TB cases was found among HCWs (19.5%) and the lowest was among IDPs (1%). Overall, the yield of TB cases per the 100k background vulnerable population was 1,519 (95% CI:1218.1–1869.9), nine times the estimated prevalence rate of 164/100k in the general population during the study period. The prevalence of TB among HCWs was the highest of all (6,286 (95% CI:3980.8–9362.3)), the least being among the IDPs (317.5 (95% CI: 80.4–1756.0)). No TB case was detected among the homeless individuals (Table 3).

Table 3. Tuberculosis case finding among the vulnerable populations in the five towns of Ethiopia, August 2017–January 2018.

Type of Vulnerable Population Result of TB screening and evaluation Total key population selected and screened Number of background key population/sampling frame Proportion of TB among the screened and evaluated Notified TB cases per 100,000 background vulnerable population (95% CI) Comparison with the estimated TB prevalence for the general population (164/100,000)
No TB TB
FSWs 203 18 221 639 8.1 2,817 (1677.8–4415.5) 17.2
IMWs 214 18 237 730 7.6 2,466 (1467.8–3869.0) 15.0
Prison inmates 1,061 27 1,112 3,400 2.4 794 (524.0–1153.3) 4.8
Residents of missionary charity 64 1 79 240 1.3 417 (105.5–2299.5) 2.5
IDPs 101 1 102 315 1 317.5 (80.4–1756.0) 1.9
HCWs 91 22 113 350 19.5 6,286 (3980.8–9362.3) 38.3
Homeless 14 0 14 55 NA NA NA
Total 1,748 87 1,878 5,729 4.6 1,519 (1218.1–1869.9) 9.3

About 1293 (69%) of the identified key population were approached for HIV testing and counseling; 1111 (59.2%) were tested and 183 (14.2%) refused testing. The overall prevalence of HIV infection, new plus already on treatment, was 67 out of the tested 1111 (6%), five times the 1.15% prevalence estimate in the general population. IMWs and FSWs represented 49.3% (33) and 28.4% (13) of the HIV infections, respectively (Table 4). Note that HIV positives reported here include those who had already known their status and were on HIV care.

Table 4. The status of HIV screening, testing, and results among the vulnerable population in five towns of Ethiopia, August 2017–January 2018.

Type of Vulnerable Population HIV test result a Total key population Total tested (%) HIV positive (%) Comparison with the estimated prevalence in the general population (1.15%)
Positive Negative Refused
FSWs 19 102 22 221 121(54.8) 15.7 13.7x
IMW s 33 127 51 237 160 (67.5) 20.6 17.9x
Prison inmates 13 671 84 1112 684 (61.5) 1.9 1.7x
Missionary facility residents 2 34 25 79 36 (45.6) 5.6 4.8x
Homeless 0 8 0 14 8 (57.1) 0.0 0x
HCWs 0 102 0 113 102 (90.3) 0.0 0x
IDP NA (note applicable) NA NA 102 NA NA NA
Total 67 1,044 182 1878 1,111 (59.2) 6.0 5.2x

Forty-nine (4.4%) of the key population with the documented HIV status had already aware that they were HIV infected and were on HIV care. Eighteen (26.9%) were new HIV-positive patients detected during the study. There were 21 (31.3%) TB cases among the HIV infected key population. HIV testing was carried out in 41 (47%) of the newly identified TB cases where 21 (51.2%) were HIV positive (S2 Table).

Factors associated with TB cases among the vulnerable population

In the bivariate analysis, having not married, being health care work, attending the lower educational level with the previous history of TB and infection with HIV have a statistically significant association with the diagnosis of TB case among the vulnerable population. In the multivariable analysis, previous history of TB disease (AOR: 11 95%; CI, 4.06–29.81), HIV infection (AOR: 7.7 95%; CI, 2.24–26.40) and being HCW (AOR: 2.42; 95% CI, 1.09–5.34) remained statistically related to active TB (Table 5).

Table 5. Bivariate and multivariable analysis of factors associated with active TB among key and vulnerable populations in the five towns of Ethiopia, August 2017–January 2018.

Variables Category (% TB case) Bivariate analysis Multivariable analysis
Crude odds ratio (COR) 95% CI AOR 95% CI
Sex (N = 87) 1. Male (70.1) 0.97 0.61–1.56 0.65 0.37–1.16
2. Female (29.9) 1
Age in years (N = 86) 1. >28 years (52.3) 1
2. >= 28 years (47.7) 0.83 0.54–1.28 0.8 0.08–7.78
Marital status (N = 80) 1. Not married (73.8) 2.98 1.80–4.95 2.09 0.86–5.06
2. Married (26.2) 1
History of TB (N = 87) 1. Yes (34.5) 11.54 6.93–1921 11 4.06–29.81
2. No (65.5) 1
Educational status(N = 80) 1. Below high school (78.8) 2.16 1.32–3.54 0.41 0.11–1.47
2. High school and above (21.3) 1
HIV status (N = 41) 1. HIV+ (51.2) 23.37 11.84–46.13 7.7 2.24–26.40
2. HIV- (48.9) 1
Type of vulnerable population (N = 85) 1. HCWs (25.9) 2.73 1.39–5.33 2.42 1.09–5.34
2. IMWs (21.2) 0.93 0.46–1.83 1.18 0.51–2.72
3. Prisoners (31.8) 0.28 0.15–0.52 0.51 0.24–1.06
4. FSWs (21.2) 1

Discussion

This study defined and identified FSWs, IMWs, missionary facility residents, prison inmates, IDPs, HCWs, and the homeless as key and vulnerable populations in the selected hotspot settings. Through the enhanced community-based TB/HIV intervention in the selected hotspot settings, we reported an overall nine times more TB cases and five times more HIV infections among the key and vulnerable population as compared to the general population. Also, the study indicated that being HCW, having HIV infection and previous episode of TB disease seem statistically associated with the development of active TB. Hence, ending the TB epidemic in Ethiopia cannot be successful without collaboration to find and treat TB and HIV at the community level among the disproportionately affected vulnerable and key populations in hotspot settings. The implementation of comprehensive, tailored and enhanced TB case finding should be prioritized in these congregate settings.

Other studies support the finding that HCWs have a high incidence and prevalence of TB [1820]. The yield of TB among the HCWs in this study is even higher than the studies in China [18,19]. This might be due to poor TB infection control at health facilities in Ethiopia [20]. Similarly, a systematic review in low- and middle-income countries indicated that the incidence rate of TB among HCWs is 2.94 times higher (95% CI, 1.67–5.19) than in the general population [21]. Although HCWs have the highest rate of TB, there was no detected HIV infection among them. The stigma associated with HIV disclosure [22] might make it difficult to find HIV-infected HCWs [23]. This could also indicate that it is worth looking for other determinants of the high TB incidence among HCWs though HIV remains a key risk factor for TB among HCWs in high-HIV-burden settings [24]. For instance, poor TB infection control in health facilities [25] and repeated exposure to TB infection and thus nosocomial TB infection [21] could explain the high TB prevalence rate among HCWs. This could partly due to greater attention to the TB symptoms and higher awareness of the disease among the HCWs. TB infections at health facilities could be due to unidentified and unsuspected TB cases [26] and the prolonged period prior to diagnosing TB cases [27]. Therefore, reducing delay in the diagnosis of TB in health facilities could be one of the approaches to lower the high TB burden among HCWs [27]. Practising comprehensive TB infection control could also reduce the high TB transmission in health facilities [25]. In addition, periodic clinical evaluation and tuberculin skin tests, and provision of preventive therapy could be considered to avert the occurrence of active TB among HCWs in Ethiopia.

As compared to other vulnerable and key populations, FSWs and IMWs were found to have a high TB case notification rate in the background of higher HIV prevalence. Both are sexually active, young and usually migrate to cash crop areas. IMWs are often the clients of FSWs at mega projects and mining areas [28]. Due to their low socioeconomic and educational status, IMWs and FSWs live in congregate and overcrowded homes and practice risky sexual behavior [28]. Hence, they are at risk of contracting and transmitting both HIV and TB infections. In addition, IMWs and FSWs play a key role in the epidemics of TB and HIV. In high-burden settings, the two diseases reinforce each other and share common risk factors [29]. So, a single service provided to people with multiple related risks represents a missed opportunity to diagnose, treat, and prevent TB or HIV. The shortcomings of this approach are evident in communities that are considered vulnerable populations [30]. Establishing and strengthening the integration of TB and HIV interventions at primary health care facilities and at the community level in hotspot settings among these vulnerable and key populations is therefore critical.

As we would expect, the yield of TB among prison inmates was five times higher than in the general population. The prevalence rate of TB among inmates in this study is higher than the rate in a recent systematic review in Ethiopia [31]. This could be because the prisoners in our study came from a hotspot area where HIV could have also contributed. However, the yield of TB case is lower than the prevalence rate reported in Côte D’Ivoire where it is 10–44 times higher than the rate in the general population [32]. This difference may be due to the variation in the diagnostic facilities and TB epidemiology between the two settings. In our study, the prison inmates represented the highest number of vulnerable and key populations screened, and they contributed to the highest proportion of overall TB case notification. So, they remain the vulnerable population most in need of tailored interventions to address TB transmission in correctional and detention centers. Like IMWs and FSWs, prisoners may also serve as a reservoir of TB and could shift the TB epidemic from correctional facilities to the community [33]. Therefore, entry and exit screenings and scheduled mass screenings are worth carrying out in correctional and detention centers in Ethiopia. Nevertheless, the prevalence of HIV infection among the prisoners was slightly higher than in the general population (1.7 vs 1.2%). Yet 11% of them refused HIV testing. The risk of TB among prisoners might not be explained only by HIV infection [34,35] but could also be due to weak implementation of TB infection control [20].

The homeless were identified as one of the vulnerable and key populations, although they were few, with no TB and HIV cases identified. Evidence shows that they have a higher burden of TB [36] due to malnutrition and addiction of various kinds, such as smoking [37]. Women who live on the street are also at high risk of sexual assault and concurrent risk for HIV infection [38] and thus for TB. The study also identified a few individuals living in missionary facilities, with low TB case identification. Some of these were children, in whom TB diagnosis is usually difficult [39]. Nevertheless, the homeless and residents of charities are at risk for TB and HIV infections. Future studies involving higher numbers of these populations could complement the investigation of the prevalence of TB and HIV infection in Ethiopia.

During the study period, Ethiopia experienced unrest that displaced several people, specifically in the eastern part of the country, where two of the study towns are located. The outreach activity to IDPs detected fewer TB cases. Evidences have reported that IDPs and other refugees are at risk for TB disease [40,41]. The longer IDPs stay in refugee centers, the higher the likelihood that they will develop TB [41]. Hence, follow-on TB and HIV screening and evaluation might detect additional TB and HIV cases. This is because overcrowding, stressful living conditions, malnutrition, and lack of access to health services could put these vulnerable people at high risk for TB [42].

The findings in this study should be interpreted cautiously, for there were limitations. Although the study included a high number of key and vulnerable populations at the community level, it should have included more homeless, refugee, cross-border refugees, children and diabetic mellitus in the other areas of the country other than the five towns. The data is skewed towards male for there were a lot of male HCWs, prison-in-mates and IDP, possibly challenging the generalization to similar settings. Only a few independent variables were considered for risk factor analysis. Thus, future studies need to investigate other risk factors for TB infection and disease in key and vulnerable populations. Besides, the shortage of the HIV testing kits made HIV testing difficult for some key population. The living situation of the homeless and the working environment of the FSW challenged the sampling and data gathering. Eventually, the crude comparison of the prevalence or notification of TB case between the national figure and the key population should consider the mixed TB case finding—of active and passive—in the general population and the enhanced active TB case finding in this study.

Conclusions

The enhanced community-based TB/HIV activity detected more HIV and TB cases among vulnerable and key populations in hotspot settings as compared to the general population. The yield of TB among HCWs and HIV prevalence among FSWs and IMWs were significant. Therefore, mapping hotspot settings and prioritizing key and vulnerable populations at high risk for TB and HIV are essential to slow the transmission of both diseases. This suggests that ending the TB epidemic and also of HIV in Ethiopia will not be successful without community-based collaboration of TB and HIV programs among the disproportionately affected vulnerable and key populations in hotspot settings.

Supporting information

S1 Fig. The map of Ethiopia with the major cities and study towns: The irregular line on the map of Ethiopia shows the administrative boundary between regions.

The cities in red colors are bigger cities in Ethiopia and are also the capital cities of the regions; they had less than 10% TB/HIV co-infection. The area with green-yellow color spot are the study towns assigned as hotspot settings for the TB and HIV, with TB/HIV co-infection of at least 10%.

(DOCX)

S1 Table. Table showing the sociodemographic details of each key population.

Age is categorized based on the median of the overall population. In the marital status, divorced and widowed were merged to show a key population without a partner. The educational category was based on grading of the Ethiopian education system. Numbers in the bracket are to show the percentage.

(DOCX)

S2 Table. This table demonstrates HIV, TB/HIV, and linkage to ART services.

HIV counseling and request for test was offered for 1293 key populations. Testing was offered for 1111 of them. 182 refused testing, and the other 585 HIV counselling and testing was not undertaken due to the shortage of HIV testing kits. Therefore, the respective TB screened 182 and 582 key populations were not tested for HIV due to refusal and shortage of HIV screening test kits.

(DOCX)

Acknowledgments

The authors wish to thank the Amhara, Dire Dawa, Harari, and Oromia Regional Health Bureaus for their strong collaboration with Challenge TB; and Barbara K. Timmons for editing the manuscript. This study was made possible by the support of the American people through the US Agency for International Development (USAID). The contents of this article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was made possible by the support of the American people through the US Agency for International Development (USAID). The contents of this article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government.

References

  • 1.World Health Organization (WHO). Global tuberculosis report 2015. Geneva: WHO; 2015 [cited 2019 May 29]. 192 p. https://apps.who.int/iris/bitstream/handle/10665/191102/9789241565059_eng.pdf?sequence=1&isAllowed=y
  • 2.WHO. Towards tuberculosis elimination: An action framework for low-incidence countries. Geneva: WHO; 2014 [cited 2019 May 29]. 67 p. https://apps.who.int/iris/bitstream/handle/10665/132231/9789241507707_eng.pdf?sequence=1
  • 3.WHO. Global tuberculosis report 2018. Geneva: WHO; 2018 [cited 2019 May 29]. 265 p. https://www.who.int/tb/publications/global_report/en/.
  • 4.Stop TB partnership. 90-(90)-90 progress report of the Global Plan to End TB 2016–2020. Geneva: WHO; 2017 [cited 2019 June 18]. http://www.stoptb.org/news/stories/2017/ns17_060.asp
  • 5.National Tuberculosis control program. National operation guide on TB key affected populations in Ethiopia and implementation plan 2018–2020. Addis Ababa, FMOH; September 2017
  • 6.Stop TB Partnership. Leave no one behind: Stop TB Partnership launches seven key population briefs [Internet]. Geneva: WHO; 2016 May 16 [cited 2019 May 31]. http://www.stoptb.org/news/stories/2016/ns16_018.asp http://www.globalfundadvocatesnetwork.org/resource/tb-key-populations-and-the-global-funds-sixth-replenishment-why-key-populations-need-a-fully-funded-global-fund-and-why-the-global-fund-needs-fully-engaged-tb-communities/.
  • 7.Hladik W, Shabbir I, Jelaludin A, Woldu A, Tsehaynesh M, Tadesse W. HIV/AIDS in Ethiopia: where is the epidemic heading?. Sexually transmitted infections. 2006. April 1;82(suppl 1):i32–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.ICF International. HIV/AIDS in Ethiopia: data from the 2011 Ethiopia demographic and health survey.
  • 9.EHNRI F. HIV Related Estimates and Projections for Ethiopia. Addis Ababa: FMoH. 2017:6–14.
  • 10.Kibret GD, Ferede A, Leshargie CT, Wagnew F, Ketema DB, Alebel A. Trends and spatial distributions of HIV prevalence in Ethiopia. Infectious diseases of poverty. 2019. December 1;8(1):90 10.1186/s40249-019-0594-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Barnabas G, Pegurri E, Selassie HH, Naamara W, Zemariam S. The HIV epidemic and prevention response in Tigrai, Ethiopia: a synthesis at sub-national level. BMC public health. 2014. December;14(1):628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sidibé M, Loures L, Samb B. The UNAIDS 90–90–90 target: a clear choice for ending AIDS and for sustainable health and development. Journal of the International AIDS Society. 2016;19(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Global Fund Advocates Network (GFAN). TB key populations and the Global Fund’s 6th replenishment: why key populations need a fully funded Global Fund and why the Global Fund needs fully engaged TB communities [Internet]. GFAN; 2018 Sep 19 [cited 2019 May 31].
  • 14.World Population Review. Ethiopia Population 2019. http://worldpopulationreview.com/countries/ethiopia-population/
  • 15.Kebede AH, Alebachew Z, Tsegaye F, Lemma E, Abebe A, Agonafir M, et al. The first population-based national tuberculosis prevalence survey in Ethiopia, 2010–2011. Int J Tuberc Lung Dis 2014; 18: 635–639. 10.5588/ijtld.13.0417 [DOI] [PubMed] [Google Scholar]
  • 16.Ethiopian Public Health Institute (EPHI). National TB/HIV sentinel surveillance one-year report (July 2011-June 2012). Addis Ababa, Ethiopia: EPHI; 2013 Mar [cited 2019 May 29]. https://www.ephi.gov.et/images/pdf/National_tbhiv_Surveillance_report.pdf
  • 17.World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017.
  • 18.Du J, Pang Y, Ma Y, Mi F, Liu Y, Li L. Prevalence of tuberculosis among health care workers in tuberculosis specialized hospitals in China. J Occup Health 2017; 59: 292–295. 10.1539/joh.16-0251-BR [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wang XN, He TL, Geng MJ, Song YD, Wang JC, Liu M, et al. Prevalence of and risk factors for tuberculosis among healthcare workers in Chinese tuberculosis facilities. Infect Dis Poverty 2018; 7: 26 10.1186/s40249-018-0407-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ayalew A, Gashu Z, Anteneh T, Hiruy N, Habte D, Jerene D, et al. Improvement in tuberculosis infection control practice via technical support in two regions of Ethiopia. BMC Infect Dis 2018; 18: 557 10.1186/s12879-018-3459-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low-and middle-income countries: a systematic review. PLoS Med 2006; 3:e494 10.1371/journal.pmed.0030494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Stringer KL, Turan B, McCormick L, Durojaiye M, Nyblade L, Kempf MC, et al. HIV-related stigma among healthcare providers in the deep south. AIDS Behav 2016; 20: 115–125. 10.1007/s10461-015-1256-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Domkam IK, Sonela N, Kamgaing N, Takam PS, Gwom LC, Betilene TM, et al. Prevalence and risk factors to HIV-infection amongst health care workers within public and private health facilities in Cameroon. Pan Afr Med J 2018; 29: 158 10.11604/pamj.2018.29.158.14073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tudor C, Van der Walt ML, Margot B, Dorman SE, Pan WK, Yenokyan G, et al. Occupational risk factors for tuberculosis among healthcare workers in KwaZulu-Natal, South Africa. Clin Infect Dis 2016; 62 (Suppl 3): S255–261. 10.1093/cid/ciw046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Tamir K, Wasie B, Azage M. Tuberculosis infection control practices and associated factors among health care workers in health centers of West Gojjam Zone, Northwest Ethiopia: a cross-sectional study. BMC Health Serv Res 2016; 16(a): 359 10.1186/s12913-016-1608-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Malakmadze N, González IM, Oemig T, Isiadinso I, Rembert D, McCauley MM, et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis 2005; 40: 366–373. 10.1086/427112 [DOI] [PubMed] [Google Scholar]
  • 27.Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis 2009; 9: 91 10.1186/1471-2334-9-91 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rocha-Jiménez T, Brouwer KC, Silverman JG, Morales-Miranda S, Goldenberg SM. Migration, violence, and safety among migrant sex workers: a qualitative study in two Guatemalan communities. Cult Health Sex 2016; 18: 965–979. 10.1080/13691058.2015.1122229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fujiwara PI, Dlodlo RA, Ferroussier O, Nakanwagi-Mukwaya A, Cesari G, Boillot F. Implementing collaborative TB-HIV activities: a programmatic guide. Paris: International Union against Tuberculosis and Lung Disease; 2012 [cited 2019 May 31]. 90 p. https://www.theunion.org/what-we-do/publications/technical/english/pub_tb-hivguide_eng_web-1.pdf
  • 30.WHO. Report of the 16th Meeting of the Strategic and Technical Advisory Group for Tuberculosis [Internet]. 45 p. Geneva: WHO; 2016 13–15 Jun [cited 2019 May 31]. https://www.who.int/tb/advisory_bodies/stag_tb_report_2016.pdf?ua=1
  • 31.Melese A, Demelash H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch Public Health 2017; 75: 37 10.1186/s13690-017-0204-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Séri B, Koffi A, Danel C, Ouassa T, Blehoué MA, Ouattara E, et al. Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Côte d’Ivoire. PloS one. 2017. July 31;12(7):e0181995 10.1371/journal.pone.0181995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sacchi FP, Praça RM, Tatara MB, Simonsen V, Ferrazoli L, Croda MG, et al. Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg Infect Dis 2015; 21: 452–455. 10.3201/eid2103.140896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Valença MS, Scaini JL, Abileira FS, Gonçalves CV, Von Groll A, Silva PE. Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology. Int J Tuberc Lung Dis 2015; 19: 1182–1187. 10.5588/ijtld.15.0126 [DOI] [PubMed] [Google Scholar]
  • 35.Alavi SM, Bakhtiarinia P, Eghtesad M, Albaji A, Salmanzadeh S. A comparative study on the prevalence and risk factors of tuberculosis among the prisoners in Khuzestan, South-west Iran. Jundishapur J Microbiol 2014; 7: e18872 10.5812/jjm.18872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bamrah S, Yelk Woodruff RS, Powell K, Ghosh S, Kammerer JS, Haddad MB. Tuberculosis among the homeless, United States, 1994–2010. Int J Tuberc Lung Dis 2013; 17: 1414–1419. 10.5588/ijtld.13.0270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Agarwal S, Nguyen DT, Graviss EA. 763. Risk factors for homeless status and mortality among Homeless TB cases in Texas, 2010–2017. Open Forum Infect Dis 2018; 5 (Suppl 1): S274 10.1093/ofid/ofy210.770 [DOI] [Google Scholar]
  • 38.Caton CL, El-Bassel N, Gelman A, Barrow S, Herman D, Hsu E, et al. Rates and correlates of HIV and STI infection among homeless women. AIDS Behav 2013; 17: 856–864. 10.1007/s10461-012-0198-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Elhassan MM, Elmekki MA, Osman AL, Hamid ME. Challenges in diagnosing tuberculosis in children: a comparative study from Sudan. Int J Infect Dis 2016; 43: 25–29. 10.1016/j.ijid.2015.12.006 [DOI] [PubMed] [Google Scholar]
  • 40.Castañeda-Hernández DM, Ramírez-Echeverri M, Sánchez-Ramírez N, Bedoya-Arias HA, Sánchez-Castaño DM, Collazos-Zapata N, et al. Comparative incidence of tuberculosis among internally displaced people of Colombia, 2009–2016. International Journal of Infectious Diseases 2018; 73 (Suppl): 345 10.1016/j.ijid.2018.04.4197. [DOI] [Google Scholar]
  • 41.Ismail MB, Rafei R, Dabboussi F, Hamze M. Tuberculosis, war, and refugees: spotlight on the Syrian humanitarian crisis. PLoS Pathog 2018; 14: e1007014 10.1371/journal.ppat.1007014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hayward S, Harding RM, McShane H, Tanner R. Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK. Version 2. F1000Res 2018; 7: 461 10.12688/f1000research.14476.2 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Hasnain Seyed Ehtesham

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

6 Mar 2020

PONE-D-20-01766

The yield of community-based enhanced tuberculosis and Human Immuno-deficiency virus case finding among key populations in selected hotspot settings of Ethiopia: a cross-sectional implementation study

PLOS ONE

Dear Dr. Dememew,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Apr 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

HASNAIN SEYED EHTESHAM

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Major Revision

Journal Requirements:

When submitting your revision, we need you to address these additional requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional information regarding the considerations  made for the prisoners included in this study. For instance, please discuss whether participants were able to opt out of the study and whether individuals who did not participate receive the same treatment offered to participants.

3. Please address the following:

- Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section, for example,  the skewed nature of the dataset towards males.

- Please refer to any sample size calculations performed prior to participant recruitment. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting).

- Please modify the title to ensure that it is meeting PLOS’ guidelines (https://journals.plos.org/plosone/s/submission-guidelines#loc-title). In particular, the title should be "specific, descriptive, concise, and comprehensible to readers outside the field". In this case, we feel that the title is not concise, for example HIV could be used instead of "Human Immuno-deficiency virus".

4. Thank you for your ethics statement : "The ethical review committee (ERC) of the respective regions of the study towns approved the study protocol."

Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

5. Please amend the manuscript submission data (via Edit Submission) to include author D. Gemechu, D. Bekele, G. Yismawu, K.Melkieneh, B. Reshu, P.G. Suarez.

6. Please amend your authorship list in your manuscript file to include author Daniel G Datiko.

7. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

 

8. We note that Figure S1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.    You may seek permission from the original copyright holder of Figure S1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

9. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is a commendable attempt that reflects the approach of precision public health in the field of TB and HIV a socioeconomically weak country having an additional burden of chronic conflict. The findings should prove valuable for control efforts in similiar settings globally. There are however some shortcomings and information gaps which should be attended to.

1. The manuscript requires language editing all through the manuscript including technical termseg. line 160 (illness is out of lung tissue: meaning extrapulmonary TB) Authors are requested to take professional help in undertaking this

2. Line 97: Please describe who are the TB focal persons

3. Line 120 : It would be helpful to know what the morbidity was at the time of data collection and which study population they represented. This could be represented in the Flow Chart which incidentally needs to be enumerated as Fig.

4. Whilst acceptance of TB and HIV screening is mentioned in the text, it would be helpful to know whether consent for both TB and HIV screenings was undertaken simultaneously or separately and were there instances where TB screening was acceptable but not HIV or vice versa

5. In a process driven paper such as this, it would be desirable to know the process in qualitative terms viz. where were the screenings undertaken, how long did it take to do the screenings and challenges during screening.

6. Line 160-163 is confusing. Do the authors imply that follow up of the confirmed TB patient was necessitated for a retrospective classification. All the more reason for the work flow to be accurately described.

7. The lack of uniformity in confirming TB diagnosis needs to be explained and the implications in computing prevalence if any

(lines 216-218)

8. An interesting but surprising finding is the minimal amount of TB detected in migrants. Were these recent or long term migrants and what was the disease status in the areas they migrated from.

9. Again a similiar scenario in homeless persons generally considered to be one of the most vulnerable. Where did these persons live: on the streets or were they institutionalized/ congregated in any way. Descriptions are necessary to understand the observations.

10. The observations do not have break up of findings as per age and gender though the information is partially provided in the tables with minimal stratification. Difficult to vizualize whether the high prevalence figures computed define certain subpopulations in the cohort. The findings need to be analyzed and represented in much more depth.

11. The discussion provides valuable insights and touches upon the risk to to HCW, the need to converge services for TB HIV (and NCDs also as in other parts of the world) and the overall lack of infection control. The low prevalence of TB in IDP is well explained. Therefore it would benefit the manuscript in the Results section to include the temporal data of the movement of the displaced persons.

12. The last sentence needs to be better formatted.

13. The message of comprehensive care through service convergence is one that is valuable in many settings and should not be ignored.

Reviewer #2: Comments to the authors:

The cross-sectional study by Dememew ZG et al. deals with the prevalence of TB and HIV in few hot-spots of Ethiopia. Ethiopia is among the top 10 high TB/HIV coinfection prevalence state. Studies are needed which identify TB or TB/HIV coinfection hot spots and also suggest measures to curb these deadly human menaces. Within the identified hot spots, they selected vulnerable population educated them about the importance of TB screening and HIV testing prior to the recruitment of the study. Although, the incidence of TB has dropped in most regions of the world including Ethiopia. However, TB with HIV coinfection is largely prevalent in vulnerable or socially excluded populations and high-risk settings. The studies are required which keep track vulnerable populations and putting them at forefront of interventions to effectively diagnose all the TB cases as well as TB/HIV coinfection. In the current study the authors detected more HIV and TB cases among vulnerable and key populations in the hotspot settings compared to the general population. This study also suggests the importance of community-based collaborations of TB and HIV programmes. The study is well designed, executed and conclusions drawn are well supported by results. The manuscript is very well written and the information provided will greatly help in the management and diagnosis of TB as well as TB/HIV coinfection cases in hot spots of Ethiopia. I have no specific reservations and suggestions for the authors. The manuscript could be considered for publication in PLOS one.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Mohd Shariq

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-20-01766.docx

PLoS One. 2020 May 29;15(5):e0233730. doi: 10.1371/journal.pone.0233730.r002

Author response to Decision Letter 0


9 May 2020

Dear Editor,

Thank you very much for giving us the chance to address the comments and suggesion from the editor and reviewer.

We have tried our best to deal with the commnets.

Best

The authors

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Hasnain Seyed Ehtesham

12 May 2020

The yield of community-based tuberculosis and HIV among key populations in hotspot settings of Ethiopia: a cross-sectional implementation study

PONE-D-20-01766R1

Dear Dr. Dememew,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

HASNAIN SEYED EHTESHAM

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The manuscript was sent for major revision and Authors have modified the manuscript keeping in mind the comments of the Reviewers. Reviewer 1 has asked some questions and sought clarifications and elaborations on some points and these have been provided by the Authors. Reviewer 2 has No major comments and others have been taken care of. I recommend this manuscript for publication.

Reviewers' comments:

Acceptance letter

Hasnain Seyed Ehtesham

13 May 2020

PONE-D-20-01766R1

The yield of community-based tuberculosis and HIV among key populations in  hotspot settings of Ethiopia: a cross-sectional implementation study 

Dear Dr. Dememew:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Hasnain Seyed Ehtesham

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The map of Ethiopia with the major cities and study towns: The irregular line on the map of Ethiopia shows the administrative boundary between regions.

    The cities in red colors are bigger cities in Ethiopia and are also the capital cities of the regions; they had less than 10% TB/HIV co-infection. The area with green-yellow color spot are the study towns assigned as hotspot settings for the TB and HIV, with TB/HIV co-infection of at least 10%.

    (DOCX)

    S1 Table. Table showing the sociodemographic details of each key population.

    Age is categorized based on the median of the overall population. In the marital status, divorced and widowed were merged to show a key population without a partner. The educational category was based on grading of the Ethiopian education system. Numbers in the bracket are to show the percentage.

    (DOCX)

    S2 Table. This table demonstrates HIV, TB/HIV, and linkage to ART services.

    HIV counseling and request for test was offered for 1293 key populations. Testing was offered for 1111 of them. 182 refused testing, and the other 585 HIV counselling and testing was not undertaken due to the shortage of HIV testing kits. Therefore, the respective TB screened 182 and 582 key populations were not tested for HIV due to refusal and shortage of HIV screening test kits.

    (DOCX)

    Attachment

    Submitted filename: PONE-D-20-01766.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES